|
|
|
|
|
|
|
|
Alligator Drug Candidates (ADC)
Alligator Bioscience is building a balanced, low risk pipeline of FIND® optimized proprietary biotherapeutics, primarily in the field of cancer and inflammation.
We have a core expertise in-house as well as a strong scientific network supporting the candidates in the area of cancer and inflammation. Furthermore, we are active in the new interface of cancer and immunology; immunotherapy of cancer.
 OK GuF o styrelsen.jpg)
AMI: Acute Myocardial Infarction
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alligator Bioscience is collaborating with Professor Thomas Tötterman, Head of Clinical Immunology, Uppsala University, a pioneer in the field of cancer immunotherapy. Within this program several immunomodulatory targets are evaluated using in vivo models.
|
“Alligator Bioscience is the ideal partner to translate our clinical and preclinical research into novel cancer therapies. Their FIND® technology enables design of protein drugs tailor made for our approach to immunotherapy.” |
 |
|
|
|
|
|
|
|
|
|